SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 29.09 |
| Enterprise Value ($M) | 20.09 |
| Book Value ($M) | 7.45 |
| Book Value / Share | 0.83 |
| Price / Book | 3.90 |
| NCAV ($M) | 7.45 |
| NCAV / Share | 0.83 |
| Price / NCAV | 3.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.30 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.15 |
| Current Ratio | 3.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.91 |
| Assets | 10.91 |
| Liabilities | 3.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | New Enterprise Associates 16, L.P. | 12.00 | -92.59 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,690 | 11,767 | 31.36 | |
| 15,840 | 40,050 | 39.55 | |
| 20,711 | 82,342 | 25.15 | |
| 2,123 | 11,615 | 18.28 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MIRA – MIRA Pharmaceuticals, Inc. | MLTX – MoonLake Immunotherapeutics |
| MNPR – Monopar Therapeutics Inc. | MTEM – Molecular Templates, Inc. |
| MTEX – Mannatech, Incorporated |
Financial data and stock pages provided by
Fintel.io